CGENMICRO

Compugen Ltd.

HealthcareBiotechnology
$2.01
$0.00(+1.00%)
52W$1.30
$3.23
Updated Jun 22, 02:00 AM
RSI33
RS Rating46/99
Beta1.71
Volatility69%
F-Score7/9
Mkt Cap$190M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Compugen Ltd. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings growth of 201% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.

Relative Strength
46
out of 99
Lagging
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.71
vs S&P 500
HIGH BETA
52W Position
37%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.58
50 SMA > 100 SMA$2.29
100 SMA > 150 SMA$2.08
150 SMA > 200 SMA$1.97

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.25-10.81%BELOW
50 SMA$2.58-22.21%BELOW
100 SMA$2.29-12.04%BELOW
150 SMA$2.08-3.56%BELOW
200 SMA$1.97+1.98%ABOVE

Price Performance

1D+1.0%
1W-1.5%
1M-29.7%
3M-7.4%
6M+33.1%
YTD+29.7%
1Y+21.8%
3Y+15.9%
52-Week Trading Range37% from low
$2.01
52W Low$1.30
52W High$3.23

Technical Indicators

RSI (14)BEARISH
32.6
305070
Setup ScoreCOOL
5/10
Base depth: 63.9%

Risk Profile

Beta
1.71
52W Vol
69%
ATR
$0.12
Max DD (1Y)
-37%

Volume Analysis

Today
503.2K
50D Avg
533.9K
Vol Ratio
0.94x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-118%
$-0.08
Q2'25+29%
$-0.08
Q3'25+32%
$-0.07
Q4'25+645%
$0.60
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+22.87%
5 Years:+105.20%
3 Years:+113.28%
TTM:+8.70%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+200.93%

Stock Price CAGR

10 Years:-11.21%
5 Years:-23.79%
3 Years:+15.93%
1 Year:+21.82%

Return on Equity

10Y Avg:-37.1%
5Y Avg:-14.3%
3Y Avg:-1.7%
Last Year:55.7%

Key Metrics

Market Cap$190M
Gross Margin87.3%
Net Margin48.6%
Piotroski F-Score7/9

Frequently Asked Questions

Is CGEN in an uptrend right now?

CGEN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CGEN overbought or oversold?

CGEN's RSI (14) is 33. The stock is in neutral territory, neither overbought nor oversold.

Is CGEN outperforming the market?

CGEN has a Relative Strength (RS) Rating of 46 out of 99. CGEN is currently lagging the broader market.

Where is CGEN in its 52-week range?

CGEN is trading at $2.01, which is 62% of its 52-week high ($3.23) and 37% above its 52-week low ($1.30).

How volatile is CGEN?

CGEN has a Beta of 1.71 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.